The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis
Abstract
Summary: Decades of research have been dedicated to the study of the opportunistic pathogen Pseudomonas aeruginosa, a Gram‐negative, environmental bacterium that secretes the exopolysaccharide alginate during chronic lung infection of cystic fibrosis (CF) patients. Although P. aeruginosa utilizes a variety of factors to establish a successful infection in the lungs of CF patients, alginate has stood out as one of the best‐studied prognostic indicators of chronic lung infection. While the genetics, biosynthesis and regulation of alginate are well understood, questions still remain concerning its role in biofilm development and its potential as a therapeutic target. The purpose of this review is to provide a brief summary of alginate biosynthesis and regulation, and to highlight recent discoveries in the areas of alginate production, biofilm formation and vaccine design. This information is placed in context with a proposed P. aeruginosa infectious pathway, highlighting avenues for the use of existing therapies as well as the potential for novel agents to reduce or eliminate chronic infections in CF patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of biofilm resistance to antimicrobial agents
Mah, T.-F. C., & O'Toole, G. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01913-2 · Cited by 3,921
Biofilm formation as microbial development
O'Toole, G., Kaplan, H. B., & Kolter, R. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.49 · Cited by 3,571
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396 · cited 2×
“Prior studies suggest that both type IV fimbriae-mediated twitching motility and quorum sensing play important roles in these processes (Davies et al., 1998; O’Toole and Kolter, 1998), although these observations might be highly dependent on the experimental conditions (Klausen et al.”
BackgroundFlagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development
O'Toole, G. A., & Kolter, R. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.01062.x · Cited by 2,697
Extracellular DNA Required for Bacterial Biofilm Formation
Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C., & Mattick, J. S. (2002) · Science · doi:10.1126/science.295.5559.1487 · Cited by 2,203 · cited 1×
“In addition to exopolysaccharides, the biofilm matrix contains a significant amount of nucleic acid (Whitchurch et al., 2002; Matsukawa and Greenberg, 2004).”
BackgroundMicrobial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 1,812
Pseudomonas aeruginosa Displays Multiple Phenotypes during Development as a Biofilm
Sauer, K., Camper, A. K., Ehrlich, G. D., Costerton, J. W., & Davies, D. G. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.4.1140-1154.2002 · Cited by 1,691 · cited 6×
“After attachment, P. aeruginosa develops microcolonies on both biotic and abiotic surfaces (O’Toole et al., 2000; Sauer et al., 2002; Jackson et al., 2003) (Fig.”
BackgroundMethodInfluentialLung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Bacterial Biofilms: An Emerging Link to Disease Pathogenesis
Parsek, M. R., & Singh, P. K. (2003) · Annual Review of Microbiology · doi:10.1146/annurev.micro.57.030502.090720 · Cited by 1,562
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519
Bacterial adhesion: seen any good biofilms lately
Dunne, W. M. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.155-166.2002 · Cited by 1,516
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
Hentzer, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg366 · Cited by 1,422
Gene expression in Pseudomonas aeruginosa biofilms
Whiteley, M., Bangera, M. G., Bumgarner, R. E., Parsek, M. R., Teitzel, G. M., Lory, S., & Greenberg, E. P. (2001) · Nature · doi:10.1038/35101627 · Cited by 1,183
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U. E., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiß, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13870 · Cited by 1,099
Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants
Klausen, M., Heydorn, A., Ragas, P., Lambertsen, L., Aaes‐Jørgensen, A., Molin, S., & Tolker‐Nielsen, T. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03525.x · Cited by 1,020
Worlitzsch, D., Tarran, R., Ulrich, M., Schwab, U., Cekici, A., Meyer, K. C., Birrer, P., Bellon, G., Berger, J., Weiss, T., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213870 · Cited by 932
Wagner, V. E., Bushnell, D., Passador, L., Brooks, A. I., & Iglewski, B. H. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.7.2080-2095.2003 · Cited by 920
Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms
Friedman, L., & Kolter, R. (2004) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03877.x · Cited by 741
Alginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function
Hentzer, M., Teitzel, G. M., Balzer, G. J., Heydorn, A., Molin, S., Givskov, M., & Parsek, M. R. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5395-5401.2001 · Cited by 693
Lam, J., Chan, R., Lam, K., & Costerton, J. W. (1980) · Infection and Immunity · doi:10.1128/iai.28.2.546-556.1980 · Cited by 649
New concepts of the pathogenesis of cystic fibrosis lung disease
Boucher, R. C. (2004) · European Respiratory Journal · doi:10.1183/09031936.03.00057003 · Cited by 640
Longitudinal Assessment of Pseudomonas aeruginosa in Young Children with Cystic Fibrosis
Burns, J. L., Gibson, R. L., McNamara, S., Yim, D., Emerson, J., Rosenfeld, M., Hiatt, P., McCoy, K., Castile, R., Smith, A. L., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/318075 · Cited by 555
Friedman, L., & Kolter, R. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4457-4465.2004 · Cited by 537
Xu, K. D., Stewart, P. S., Xia, F., Huang, C.-T., & McFeters, G. A. (1998) · Applied and Environmental Microbiology · doi:10.1128/aem.64.10.4035-4039.1998 · Cited by 499
Mathee, K., Ciofu, O., Sternberg, C., Lindum, P. W., Campbell, J. I. A., Jensen, P., Johnsen, A. H., Givskov, M., Ohman, D. E., Søren, M., et al. (1999) · Microbiology · doi:10.1099/13500872-145-6-1349 · Cited by 484
Frederiksen, B., Koch, C., & Høiby, N. (1997) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199705)23:5<330::aid-ppul4>3.0.co;2-o · Cited by 473
Wozniak, D. J., Wyckoff, T. J. O., Starkey, M., Keyser, R., Azadi, P., O'Toole, G. A., & Parsek, M. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1231792100 · Cited by 466
Self-citationWu, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh223 · Cited by 446
Feltman, H., Schulert, G., Khan, S., Jain, M., Peterson, L., & Hauser, A. R. (2001) · Microbiology · doi:10.1099/00221287-147-10-2659 · Cited by 446
Jackson, K. D., Starkey, M., Kremer, S., Parsek, M. R., & Wozniak, D. J. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4466-4475.2004 · Cited by 421
Self-citationNivens, D. E., Ohman, D. E., Williams, J., & Franklin, M. J. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.3.1047-1057.2001 · Cited by 416
Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
Martin, D. W., Schurr, M. J., Mudd, M. H., Govan, J. R., Holloway, B. W., & Deretic, V (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8377 · Cited by 392
Sawa, T., Yahr, T. L., Ohara, M., Kurahashi, K., Gropper, M. A., Wiener-Kronish, J. P., & Frank, D. W. (1999) · Nature Medicine · doi:10.1038/7391 · Cited by 362
and the in vitroand in vivo biofilm mode of growth
Høiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O., & Kharazmi, A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01349-6 · Cited by 356
Bacterial alginates: biosynthesis and applications
Rehm, B. H. A., & Valla, S. (1997) · Applied Microbiology and Biotechnology · doi:10.1007/s002530051051 · Cited by 342
Role of alginate lyase in cell detachment of Pseudomonas aeruginosa
Boyd, A., & Chakrabarty, A. M. (1994) · Applied and Environmental Microbiology · doi:10.1128/aem.60.7.2355-2359.1994 · Cited by 336
Putative Exopolysaccharide Synthesis Genes Influence Pseudomonas aeruginosa Biofilm Development
Matsukawa, M., & Greenberg, E. P. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4449-4456.2004 · Cited by 336
Hassett, D. J., Cuppoletti, J., Trapnell, B., Lymar, S. V., Rowe, J. J., Sun Yoon, S., Hilliard, G. M., Parvatiyar, K., Kamani, M. C., Wozniak, D. J., et al. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00152-7 · Cited by 313
Self-citationA New Polysaccharide Resembling Alginic Acid Isolated from Pseudomonads
Linker, A., & Jones, R. S. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99848-0 · Cited by 306
Boucher, J. C., Yu, H., Mudd, M. H., & Deretic, V (1997) · Infection and Immunity · doi:10.1128/iai.65.9.3838-3846.1997 · Cited by 282
Baltimore, R. S., Christie, C. D. C., & Smith, G. J. W. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.6.1650 · Cited by 274
Pseudomonas aeruginosa quorum sensing as a potential antimicrobial target
Smith, R. S., & Iglewski, B. H. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320364 · Cited by 271
Pier, G. B., Coleman, F., Grout, M., Franklin, M., & Ohman, D. E. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1895-1901.2001 · Cited by 258
Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen, S. S., Hoiby, N., Espersen, F., & Koch, C. (1992) · Thorax · doi:10.1136/thx.47.1.6 · Cited by 240
Deretic, V, Dikshit, R., Konyecsni, W. M., Chakrabarty, A. M., & Misra, T. K. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.3.1278-1283.1989 · Cited by 224
Biofilms 2003: Emerging Themes and Challenges in Studies of Surface-Associated Microbial Life
Parsek, M. R., & Fuqua, C. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.14.4427-4440.2004 · Cited by 216
DeVries, C. A., & Ohman, D. E. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.21.6677-6687.1994 · Cited by 204
Nikolskaya, A. N. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.11.2453 · Cited by 201
Bacterial alginate biosynthesis – recent progress and future prospects
Gacesa, P. (1998) · Microbiology · doi:10.1099/00221287-144-5-1133 · Cited by 197
Pseudomonas aeruginosa AlgG is a polymer level alginate C5-mannuronan epimerase
Franklin, M. J., Chitnis, C. E., Gacesa, P., Sonesson, A., White, D. C., & Ohman, D. E. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.7.1821-1830.1994 · Cited by 193
Stapper, A. P., Narasimhan, G., Ohman, D. E., Barakat, J., Hentzer, M., Molin, S., Kharazmi, A., Høiby, N., & Mathee, K. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45539-0 · Cited by 186
Schultz, M. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh309 · Cited by 185
Martin, D. W., Holloway, B. W., & Deretic, V (1993) · Journal of Bacteriology · doi:10.1128/jb.175.4.1153-1164.1993 · Cited by 183
Effects of Subinhibitory Concentrations of Macrolide Antibiotics on Pseudomonas aeruginosa
Wozniak, D. J., & Keyser, R. (2004) · Chest · doi:10.1378/chest.125.2_suppl.62s · Cited by 183
Self-citationMathee, K., McPherson, C. J., & Ohman, D. E. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.11.3711-3720.1997 · Cited by 181
Scavenging by alginate of free radicals released by macrophages
Simpson, J. A., Smith, S. E., & Dean, R. T. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90078-6 · Cited by 177
Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response
Pedersen, S. S., Kharazmi, A., Espersen, F., & Høiby, N. (1990) · Infection and Immunity · doi:10.1128/iai.58.10.3363-3368.1990 · Cited by 177
Hershberger, C. D., Ye, R. W., Parsek, M. R., Xie, Z. D., & Chakrabarty, A. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7941 · Cited by 171
Boucher, J. C., Martinez-Salazar, J., Schurr, M. J., Mudd, M. H., Yu, H., & Deretic, V (1996) · Journal of Bacteriology · doi:10.1128/jb.178.2.511-523.1996 · Cited by 161
Franklin, M. J., & Ohman, D. E. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.16.5057-5065.1993 · Cited by 159
Characterization and regulation of the Pseudomonas aeruginosa algC gene encoding phosphomannomutase
Zielinski, N. A., Chakrabarty, A. M., & Berry, A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)92885-1 · Cited by 158
Wolfgang, M. C., Jyot, J., Goodman, A. L., Ramphal, R., & Lory, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307553101 · Cited by 158
Microarray Analysis of Global Gene Expression in Mucoid Pseudomonas aeruginosa
Firoved, A. M., & Deretic, V. P. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.3.1071-1081.2003 · Cited by 157
Gimmestad, M., Sletta, H., Ertesvåg, H., Bakkevig, K., Jain, S., Suh, S., Skjåk‐Bræk, G., Ellingsen, T. E., Ohman, D. E., & Valla, S. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.12.3515-3523.2003 · Cited by 155
Garrett, E. S., Perlegas, D., & Wozniak, D. J. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.23.7401-7404.1999 · Cited by 153
Self-citationShinabarger, D. L., Berry, A., May, T. B., Rothmel, R. K., Fialho, A. M., & Chakrabarty, A. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52212-2 · Cited by 152
An atypical Pseudomonas aeruginosa associated with cystic fibrosis of the pancreas
Doggett, R. G., Harrison, G. M., Stillwell, R. N., & Wallis, E. S. (1966) · The Journal of Pediatrics · doi:10.1016/s0022-3476(66)80152-x · Cited by 152
Aaron, S. D., Ferris, W., Ramotar, K., Vandemheen, K. L., Chan, F., & Saginur, R. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.4172-4179.2002 · Cited by 148
Schnider‐Keel, U., Lejbølle, K. B., Baehler, E., Haas, D., & Keel, C. (2001) · Applied and Environmental Microbiology · doi:10.1128/aem.67.12.5683-5693.2001 · Cited by 138
Schiller, N. L., Monday, S. R., Boyd, C. M., Keen, N. T., & Ohman, D. E. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.15.4780-4789.1993 · Cited by 130
Rosenfeld, M., Ramsey, B. W., & Gibson, R. L. (2003) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200311000-00008 · Cited by 124
Pseudomonas aeruginosa, mucoidy and the chronic infection phenotype in cystic fibrosis
Deretic, V. P., Schurr, M. J., & Yu, H. D. (1995) · Trends in Microbiology · doi:10.1016/s0966-842x(00)88974-x · Cited by 120
Martin, D. W., Schurr, M. J., Mudd, M. H., et al. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01711.x · Cited by 120
Frisk, A., Schurr, J. R., Wang, G., BERTUCCI, D. C., Marrero, L., Hwang, S. H., Hassett, D. J., & Schurr, M. J. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5433-5438.2004 · Cited by 114
A mutation in algN permits trans activation of alginate production by algT in Pseudomonas species
Goldberg, J. B., Gorman, W. L., Flynn, J. L., & Ohman, D. E. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.5.1303-1308.1993 · Cited by 113
Coleman, F. T., Müschenborn, S., Meluleni, G. J., Ray, C., Carey, V. J., Vargas, S. O., Cannon, C. L., Ausubel, F. M., & Pier, G. B. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437901100 · Cited by 111
Dual regulation of mucoidy in Pseudomonas aeruginosa and sigma factor antagonism
Boucher, J. C., Schurr, M. J., & Deretic, V. P. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01846.x · Cited by 108
Firoved, A. M., Boucher, J. C., & Deretic, V. P. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.4.1057-1064.2002 · Cited by 103
Pier, G. B., Boyer, D. M., Preston, M. J., Coleman, F. T., Llosa, N. J., Mueschenborn-Koglin, S., Theilacker, C., Goldenberg, H. B., Uchin, J., Priebe, G. P., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5671 · Cited by 101
Pseudomonas aeruginosa Contains an IHF-like Protein That Binds to the algD Promoter
Toussaint, B., Attrée, I., & Vignais, P. M. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2265 · Cited by 98
Human immune response to Pseudomonas aeruginosa mucoid exopolysaccharide (alginate) vaccine
Pier, G. B., DesJardin, D., Grout, M., Garner, C. T., Bennett, S. E., Pekoe, G., Fuller, S., Thornton, M. O., Harkonen, W. S., & Miller, H. (1994) · Infection and Immunity · doi:10.1128/iai.62.9.3972-3979.1994 · Cited by 93
Kato, J., Misra, T. K., & Chakrabarty, A. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.2887 · Cited by 92
Jain, S., & Ohman, D. E. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.3.634-641.1998 · Cited by 89
AlgX Is a Periplasmic Protein Required for Alginate Biosynthesis in Pseudomonas aeruginosa
Robles-Price, A. G., Wong, T. Y., Sletta, H., Valla, S., & Schiller, N. L. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.21.7369-7377.2004 · Cited by 82
Structural Basis of Diverse Substrate Recognition by the Enzyme PMM/PGM from P. aeruginosa
Regni, C. A., Naught, L. E., Tipton, P. A., & Beamer, L. J. (2004) · Structure · doi:10.1016/j.str.2003.11.015 · Cited by 81
Konyecsni, W. M., & Deretic, V. P. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.5.2511-2520.1990 · Cited by 80
Alginate synthesis in Pseudomonas aeruginosa: the role of AlgL (alginate lyase) and AlgX
Monday, S. R., & Schiller, N. L. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.3.625-632.1996 · Cited by 79
Silo-Suh, L., Suh, S., Sokol, P. A., & Ohman, D. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242343999 · Cited by 78
Virulence properties of Pseudomonas aeruginosa lacking the extreme-stress sigma factor AlgU (sigmaE)
Yu, H. D., Boucher, J. C., Hibler, N. S., & Deretic, V. P. (1996) · Infection and Immunity · doi:10.1128/iai.64.7.2774-2781.1996 · Cited by 75
Firoved, A. M., Ornatowski, W., & Deretic, V. P. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5012-5018.2004 · Cited by 74
Baynham, P. J., Brown, A. L., Hall, L. L., & Wozniak, D. J. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01550.x · Cited by 73
Self-citationJain, S., Franklin, M. J., Ertesvåg, H., Valla, S., & Ohman, D. E. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03361.x · Cited by 73
Yanagihara, K. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf013 · Cited by 72
Gilboa‐Garber, N., Mizrahi, L., & Garber, N. C. (1972) · FEBS Letters · doi:10.1016/0014-5793(72)80685-9 · Cited by 70
Boucher, J. C., Schurr, M. J., Yu, H. D., Rowen, D. W., & Deretic, V. P. (1997) · Microbiology · doi:10.1099/00221287-143-11-3473 · Cited by 70
Goldberg, J. B., & Dahnke, T. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb00837.x · Cited by 69
Pedersen, S. S., Espersen, F., Høiby, N., & Jensen, T. G. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.4.747-755.1990 · Cited by 62
Chu, L. P., May, T. B., Chakrabarty, A. M., & Misra, T. K. (1991) · Gene · doi:10.1016/0378-1119(91)90290-r · Cited by 54
Darling, K., Dewar, A. L., & Evans, T. J. (2004) · Cellular Microbiology · doi:10.1111/j.1462-5822.2004.00380.x · Cited by 52
Changes in strategies for optimal antibacterial therapy in cystic fibrosis
Ratjen, F. A. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00333-2 · Cited by 48
Attrée, I., Toussaint, B., Garin, J., & Vignais, P. M. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4121799.x · Cited by 47
Controlof Pseudomonas aeruginosa algZ Expression bythe Alternative Sigma FactorAlgT
Wozniak, D. J., Sprinkle, A. B., & Baynham, P. J. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.24.7297-7300.2003 · Cited by 45
Self-citationFujiwara, S., Zielinski, N. A., & Chakrabarty, A. M. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.17.5452-5459.1993 · Cited by 38
Mitsuya, Y., Kawai, S., & Kobayashi, H. (2000) · Journal of Infection and Chemotherapy · doi:10.1007/s101560050049 · Cited by 33
Research works printed but not linked: 28
- 10.1099/00221287-143-2-641 · doi:10.1099/00221287-143-2-641
- 10.1111/j.1365-2958.1996.tb02659.x · doi:10.1111/j.1365-2958.1996.tb02659.x
- Cryz S., 1997, Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O‐polysaccharide‐toxin A conjugate vaccine, Behring Inst Mitt, 98, 345
- Cystic Fibrosis Foundation., 2001, Cystic Fibrosis Foundation Patient Registry Annual Report.
- 10.1111/j.1365-2958.1991.tb02096.x · doi:10.1111/j.1365-2958.1991.tb02096.x
- Doring G., 1997, A multicenter vaccine trial using the Pseudomonas aeruginosa flagella vaccine IMMUNO in patients with cystic fibrosis, Behring Inst Mitt, 98, 338
- 10.1136/adc.85.1.62 · doi:10.1136/adc.85.1.62
- 10.1128/mr.60.3.539-574.1996 · doi:10.1128/mr.60.3.539-574.1996 · Paper page
- 10.1111/j.1574-6968.1990.tb04127.x · doi:10.1111/j.1574-6968.1990.tb04127.x
- 10.1128/IAI.69.11.6962-6969.2001 · doi:10.1128/iai.69.11.6962-6969.2001
- 10.1055/s-2004-815662 · doi:10.1055/s-2004-815662
- 10.1016/0378-1119(89)90136-4 · doi:10.1016/0378-1119(89)90136-4
- 10.1074/jbc.272.29.17952 · DOI
- 10.1016/0378-1119(93)90477-K · doi:10.1016/0378-1119(93)90477-k
- 10.1046/j.1365-2958.2003.03525.x · DOI · Paper page
- 10.1016/S0378-1119(97)00380-6 · doi:10.1016/s0378-1119(97)00380-6
- 10.1128/jb.174.20.6624-6633.1992 · doi:10.1128/jb.174.20.6624-6633.1992
- Pier G.B., 1998, Pseudomonas aeruginosa: a key problem in cystic fibrosis, ASM News, 6, 339
- 10.1128/IAI.69.5.3510-3515.2001 · doi:10.1128/iai.69.5.3510-3515.2001
- 10.1046/j.1365-2958.2000.01830.x · doi:10.1046/j.1365-2958.2000.01830.x
- 10.1128/jb.177.9.2469-2474.1995 · doi:10.1128/jb.177.9.2469-2474.1995
- 10.1021/bi027328k · doi:10.1021/bi027328k
- 10.1099/13500872-140-7-1745 · doi:10.1099/13500872-140-7-1745
- 10.1128/IAI.71.7.3875-3884.2003 · doi:10.1128/iai.71.7.3875-3884.2003
- 10.1073/pnas.93.18.9839 · doi:10.1073/pnas.93.18.9839
- 10.1128/jb.176.16.5068-5076.1994 · doi:10.1128/jb.176.16.5068-5076.1994
- 10.1128/jb.173.4.1406-1413.1991 · doi:10.1128/jb.173.4.1406-1413.1991
- 10.1128/jb.179.1.187-193.1997 · DOI
Cited by
Alginate derivatization: A review of chemistry, properties and applications
Pawar, S. N., & Edgar, K. J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.007 · Cited by 1,627
Signals, Regulatory Networks, and Materials That Build and Break Bacterial Biofilms
Karatan, E., & Watnick, P. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00041-08 · Cited by 1,048
Bacterial Extracellular Polysaccharides in Biofilm Formation and Function
Limoli, D. H., Jones, C. J., & Wozniak, D. J. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mb-0011-2014 · Cited by 924
Self-citationThe Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections
Driscoll, J. A., Brody, S. L., & Kollef, M. H. (2007) · Drugs · doi:10.2165/00003495-200767030-00003 · Cited by 884
Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance
Uruén, C., Chopo-Escuin, G., Tommassen, J., Mainar-Jaime, R. C., & Arenas, J. (2020) · Antibiotics · doi:10.3390/antibiotics10010003 · Cited by 769
Metadata
- Authors
- Ramsey, D. M., & Wozniak, D. J.
- Venue
- Molecular Microbiology
- Publisher
- Wiley
- Published
- 2005-03-07
- Volume
- 56
- Issue
- 2
- Pages
- 309-322
- ISSN
- 0950-382X (ISSN-L)
- 1365-2958
- OpenAlex
- W2123818413
- Cited by
- 391
- References
- 106
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.